Status:
WITHDRAWN
Effective Pain Management During Shoulder Replacement Surgery With EXPAREL
Lead Sponsor:
TriHealth Inc.
Conditions:
Pain, Postoperative
Shoulder Osteoarthritis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to examine the effectiveness of post-operative pain control of local infiltration (LIA) of EXPAREL administration to ropivacaine administered via continuous interscalene n...
Detailed Description
Shoulder replacement surgery is recognized as having the potential to cause a considerable amount of pain that may require opioid consumption for several days post-operatively. The side effects of opi...
Eligibility Criteria
Inclusion
- Surgical candidate for primary total shoulder replacement or reverse total shoulder replacement
- Patient must be 18 years or older
- Patient must be willing and able to sign IRB approved informed consent form, and must be able to understand and agree to follow study protocol.
Exclusion
- Severe bronchopulmonary disease
- Oxygen dependent
- Existing nerve injury
- BMI \> 40
- Coagulation disorders
- Allergy to ropivicaine or bupivacaine
- History of drug or alcohol abuse
- Opioid use within 3 days prior to surgery
- ASA physical status \> lll
- Discharge plan to Skilled nursing facility
- Pregnant women
- Non-English speaking patients
Key Trial Info
Start Date :
March 17 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03474510
Start Date
March 17 2018
End Date
February 1 2019
Last Update
March 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Good Samarian Hospital
Cincinnati, Ohio, United States, 45220